What We Already Know Reported as a cause of anaphylaxis since the 1960s Cardiovascular collapse is the commonest presentation Allergic reactions can be.

Slides:



Advertisements
Similar presentations
Simulation in Anaesthesia at the Royal Adelaide Hospital
Advertisements

Dr. A conducts preoperative assessment checked into surgery by Ms. KMrs. Bromily assures Ms. K her fused vertebre will not be a problem intravenous cannula.
Anaphylaxis and Epinephrine The Role of the EMT-Basic N.H. Patient Care Protocols N.H. Department of Safety Division of Fire Standards & Training and Emergency.
Anaesthetic Emergencies Acute Anaphylaxis Dr T E Allan Palmer FRCA FANZCA MD
The College of Emergency Medicine Acute Allergic Reaction.
421 MDS Course Course Director: Dr Asmaa Faden Faden Course Contributors: Prof. A AlDosari.
Yuksel E, Duman D, Yeniay L,Ulukaya S SUBCUTANEOUS ISOSULFAN BLUE ADMINISTRATION MAY INTERFERE WITH PULSE OXIMETRY.
Allergic Reactions and You Dana Daidone D.O.. Onset of Reaction Usually within minutes after injection 80% occur on induction 15% during maintenance 5%
Anaphylaxis: Rapid recognition and treatment Miha Mežnar MD Medical intensive care unit General hospital Celje, Slovenia.
Allergy in 10 minutes DETECTIVE WORK Presenting episode Previous episodes Consistent trigger or pattern to episodes Contacts/Foods in previous 4 hours.
Anaphylaxis Alex Pearce-Smith. Scenario A patient who is well but has been called in for a medication review has just sat down. Suddenly the practice.
Coagulants By: Autum White. Sources   
دکتر افشین شیرکانی فوق تخصص آسم و آلرژی و بیماری های نقص ایمنی عضو آکادمی آسم و آلرژی و ایمونولوژی آمریکا استادیار دانشگاه.
References 1.Royal College of Anaesthetists 3 rd National Audit Project (NAP3) Major Complications of Central Neuraxial Block in the United Kingdom, Report.
Mohan Kamalanathan Emergency Department Frankston Hospital
HILLINGDON th April 2009Hillingdon Masterclass.
NAP6 Perioperative Anaphylaxis The Royal College of Anaesthetists’ 6 th National Audit Project Starting on 5 th February 2016.
Bacterial meningitis and meningococcal septicaemia Implementing NICE guidance June 2010 NICE clinical guideline 102.
iMAP Guideline for Primary Care and ‘First Contact’ Clinicians
Anaphylaxis Tariq El-Shanawany, University Hospital of Wales, UK
WiFi name: WifiLoveMCR Password: internet Join the conversation on Twitter using #DrivingChange
Jessica Case study.
Transforming Outpatients Project
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Nursing.
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Paediatric Atopic Eczema
A Single Centre Experience In Managing Anaphylaxis In The Emergency Department Iman Nasr1; Joanna Lukawska1,2; Runa Ali1; Ikram Nasr3; Jason Pott1; Tim.
NAP6 Perioperative Anaphylaxis
Foundations of Interprofessional Collaboration (FIPC): An Introduction to TeamSTEPPS® LEVEL 3 Overview of Clinical Management of Anaphylaxis for Respiratory.
Jane E Scullion Respiratory Nurse Consultant
Emergency Management of Anaphylaxis
PSO – Paper Switch Off Project
A call to the resus room Dr Hilary Glaisyer July 2017
Management of infective endocarditis- a Quality Improvement project
SBAR Situation Background Assessment Recommendation
Overview and Key Findings Prof Nigel Harper Clinical Lead, NAP6
Pathway for patients with suspected Breast Cancer
Achieving World-Class Cancer Outcomes A Strategy for England
ايمني بيمار PATIENT SAFETY حق بيمار و مسئوليت ما
CLINICAL FEATURES Dr K-L Kong, MD MBBS FRCA, Consultant Anaesthetist Dr Surendra Karanam, BSc MBBS MRCP FRCP FRCPath, Consultant Immunologist.
Allergy Clinic Perceptions: The NAP6 Baseline survey Prof
Allergy Testing in Children
Immediate Management Prof Nigel Harper Clinical Lead, NAP6
Obstetrics Nuala Lucas OAA
NAP6 – deaths, cardiac arrests, profound hypotension and outcomes Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
Antibiotics Shuaib Nasser Cambridge University Hospitals NHS Foundation Trust NAP6 Steering Committee member.
Chlorhexidine Tomaz Garcez Consultant Immunology
NAP6 Paediatric cases Mark Thomas Paediatric Anaesthetist Great Ormond Street Hospital, London Council member, Association of Paedaitrc Anaesthetists.
Objectives of patients flow map
ايمني بيمار PATIENT SAFETY حق بيمار و مسئوليت ما
Achieving World-Class Cancer Outcomes A Strategy for England
Investigations: The NAP6 Data Prof
Achieving World-Class Cancer Outcomes A Strategy for England
Recognising sepsis and taking action
NAP 6 Tools Tomaz Garcez Consultant Immunologist
NAP6 – the independent/private sector m Tim Cook Director of NAP program Consultant Anaesthesia/Intensive Care, Bath.
What we already know Most studies have shown that NMBAs are the commonest cause (44-60%)of perioperative anaphylaxis Previous studies have been hampered.
Aims Assess baseline practice Explore experience of previous cases
Achieving World-Class Cancer Outcomes A Strategy for England
The Patient Experience Mr John Hitchman RCoA Lay Representative
S B A R SBAR Information Tool
5 phases Baseline survey of anaesthetists perspectives/experiences
Pharmaceutical care planning 2 Ola Ali Nassr
Delayed transfers of care | Overview
Pathway for patients with suspected Breast Cancer
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit.
Anaphylaxis: Rapid recognition and treatment
Louise Johnson General Manager Emergency Care
When the Swiss cheese aligns - Making a clinical error
Presentation transcript:

Patent Blue Dye Sophie Farooque Consultant in Allergy; Imperial College Healthcare NHS Trust

What We Already Know Reported as a cause of anaphylaxis since the 1960s Cardiovascular collapse is the commonest presentation Allergic reactions can be delayed Can interact with the pulse oximeter  falsely low saturations

Incidence of Anaphylaxis to Patent Blue Dye Fourth most common cause of anaphylaxis in NAP6 Teicoplanin (16.4 per 100,000) Patent Blue Dye (14.6 per 100,000 administrations) Suxamethonium (11.1 per 100,000)

Demographics Nine cases None were fatal Profound hypotension was common Two thirds of patients required transfer to critical care Surgery completed in seven patients but abandoned in two

Presenting Features One third of patients had no skin signs Urticaria was a presenting feature in only one patient Hypotension was the commonest presenting feature Hypotension was universal in all cases Desaturation was the second commonest presenting feature

Latency Reactions can be delayed In five patients more than 10 minutes after injection In two patients more than 60 minutes after injection

Diagnostically Challenging. Delay in onset Falsely low pulse oximeter readings Skin signs are rarely a presenting feature Dynamic tryptase change seen in 75% of patients

Resuscitation Good (2) Good and Poor (5) Poor (2) Adrenaline CPR

Allergy Clinic Assessment Good (4) Good and Poor (2) Poor (1) Not assessed (1) Failure to investigate all culprit drugs

Referrals Good correlation between anaesthetists’ suspicion and confirmation by the allergy clinics and the NAP6 review panel Referrals mostly good Methylene blue/Patent blue mixed up Proceeded straight further surgery

What Do If Surgery is Abandoned? Urgent allergy clinic assessment Proceeding with surgery before allergy clinic investigation Non-operative treatments. Communicate! Urgent discussion with the allergy clinic is likely to be useful

Key Recommendations Consent Do not assume patent blue dye is the culprit Refer. Evaluate all drugs If pulse oximeter saturations fall during anaphylaxis, assume it is real. Take a blood gas once the patient is stable

Thank you